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Free radicalsThe “angiogenic switch” during tumor progression is increasingly recognized as a milestone event in
tumorigenesis, although the surprising prometastatic effect of antiangiogenic therapies has recently shaken
the scientific community. Tumor hypoxia has been singled out as a possible responsible factor in this
prometastatic effect, although the molecular pathways are completely unknown. We report herein that human
melanoma cells respond to hypoxia through a deregulation of the mitochondrial release of reactive oxygen
species (ROS) by the electron transfer chain complex III. These ROS aremandatory to stabilize hypoxia-inducible
factor-1α (HIF-1α), themaster transcriptional regulator of the hypoxic response.We found that melanoma cells
sense hypoxia-enhancing expression/activation of the Met proto-oncogene, which drives a motogenic escape
program. Silencing analyses revealed a definite hierarchy of this process, in which mitochondrial ROS drive HIF-
1α stabilization,which in turn activates theMet proto-oncogene. This pathway elicits a clearmetastatic program
ofmelanoma cells, enhancing spreading on extracellular matrix, motility, and invasion of 3Dmatrices, as well as
growth of metastatic colonies and the ability to form capillary-like structures by vasculogenic mimicry. Both
pharmacological and genetic interferencewithmitochondrial ROS delivery orMet expression block the hypoxia-
drivenmetastatic program. Hence, we propose that hypoxia-driven ROS act as a primary driving force to elicit an
invasive program exploited by aggressive melanoma cells to escape from a hypoxic hostile environment.ematoxylin and eosin; HGF,
ctor; NAC, N-acetylcysteine;
oxylase; ROS, reactive oxygen
mical Sciences, University of
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melanoma, are characterized by hypoxic areas originating from an
imbalance between oxygen supply and expenditure in the actively
proliferating tumor cells [1]. Oxygen supply is further worsened by an
inadequate tumor vasculature until de novo angiogenesis is induced
[2,3]. The presence of hypoxic areas within a tumor mass is invariably
a poor prognosis marker for patients with a range of cancer types,
including aggressivemelanoma [4]. Furthermore, the failure of overall
survival benefit due to increased metastatic dissemination after
antiangiogenic therapies suggests that hypoxia may cooperate with
endothelial inflammation for metastasis spread [5–7].
Metastasis is a multistep route in which cancer cells should gain
motile features, become able to degrade the extracellular matrix (ECM),and enter the blood and lymphatic vessels. Metastatic cells should then
survive to anoikis, while being without a proper ECM attachment, elude
immunosurveillance, home to target distant sites, and finally grow in the
new environment [8]. Tumor hypoxia can affect most of these steps,
indeed: (i) it activates a glycolytic metabolism of tumors cells, thereby
allowing survival within the hypoxic environment; (ii) it increases
invasion by regulating the transition toward a mesenchymal phenotype
(the so-called epithelial–mesenchymal transition), by promoting the
degradation and remodeling of the ECM through increased production of
urokinase-type plasminogen activator receptor and metalloproteinase-2
[9,10], aswell as by regulatingmotogenic growth factor receptors such as
hepatocyte growth factor receptor (HGF)/Met [11]; (iii) tumor hypoxia
contributes to tumor angiogenesis via induction of proangiogenic factors
such as vascular endothelial growth factor (VEGF) or interleukin-8 and
angiopoietin-2 [12,13]; (iv) hypoxia also increases resistance to anoikis
by suppression of α5 integrin [14]; and (v) finally, by increasing the
expressionof lysyl oxidase, hypoxiaprepares a receptive environment for
metastatic cells through the recruitment to the metastatic niche of bone
marrow-derived cells [15].
The hypoxia-inducible factors (HIFs) mediate transcriptional
responses to changes in oxygen levels by activating the transcription
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composed of HIF-1α and HIF-1β subunits, belonging to the basic
helix–loop–helix superfamily of transcription factors. The HIF-1α
subunit is subjected to O2-dependent asparaginyl and prolyl hydrox-
ylation, leading respectively to loss of transcriptional activity or
binding to von Hippel–Landau ubiquitin ligase and proteasomal
degradation of HIF-1α. Under hypoxic conditions, the hydroxylation
reactions are inhibited, and HIF-1α is stabilized and competent to
activate transcription of target genes. Among the first HIF-1 target
genes to be identified were the human VEGF gene, several glycolytic
enzymes, and several motility factors and their receptors.
Recent data implicatemitochondrial ROSproductionobserved inmild
hypoxia (1–3% O2) in HIF-1α stabilization. In contrast to expectation,
limited oxygen increases mitochondrial ROS rather than diminishing
them [17,18]. ROS, in turn, inactivate prolyl hydroxylases (PHDs),
through oxidation of the ferrous ion that is essential for their catalytic
mechanism, and hence stabilize HIF-1α. Vitamin C has been shown to
decrease HIF-1 levels by preventing the oxidation of the catalytic ferrous
ion [18,19]. In keeping with this, it has been recently reported that the
antitumorigenic effect of antioxidants as N-acetylcysteine (NAC) and
vitamin C in murine models of Myc-mediated tumorigenesis are indeed
HIF-1-dependent [20].
Hypoxia has now received attention in the progression of aggressive
melanoma.HIF-1plays a critical role inuvealmelanomaby increasing the
expression of a number of target genes involved in invasion [21] and is
currently considered one of the critical biomarkers predicting liver
metastasis [22]. Furthermore, a recent study by Qi and colleagues [23]
supports a role in melanoma development and metastasis of Siah2, a
ubiquitin ligase that regulates PHDs, leading to a stabilization of HIF-1α
under hypoxic conditions. Moreover, HIF-1α expression in melanoma
samples has been associated with poor overall disease survival [24].
Hypoxia has been additionally linked to vasculogenic mimicry of B16
mouse melanoma, thereby suggesting a facilitation of blood supply and
metastasis dissemination [25].
Although these observations strongly suggest a role for hypoxia
and HIF signaling in melanoma progression, the mechanistic aspect of
hypoxia/HIF-mediated melanoma progression still remains relatively
unexplored. We report herein that in Hs29-4T humanmelanoma cells
hypoxia leads to a redox-dependent stabilization of HIF-1α, mainly
mediated by mitochondrial ROS. This in turn leads to increased
expression and activation of the proto-oncogeneMet and to activation
of the motogenic and invasive program of melanoma cells. Elimina-
tion of mitochondrial ROS production during hypoxia leads to a strong
decrease in melanoma cell invasiveness and lung experimental
metastasis formation.
Material and methods
Materials
Unless specified all reagents were obtained from Sigma. Hs29-4T
cells were from the ATCC, all antibodies were from Santa Cruz
Biotechnology, except for the anti-HIF-1α, which was from BD
Biosciences. 2′,7′-Dichlorofluorescein diacetate (DCF-DA) was from
Molecular Probes and the ATP-competitive inhibitor of Met kinase
PHA-665752 (PHA) was from Tocris. Polyvinylidene difluoride was
from Millipore and Matrigel was from BD Biosciences. siRNA
oligonucleotides targeting HIF-1α (target sequence 5′-AAAGGACAA-
GUCACCACAGGA-3′) and siRNA targeting the Rieske iron–sulfur
protein (target sequence 5′-AAUGCCGUCACCCAGUUCGUU-3′) were
obtained from Qiagen.
Cell culture and transfections
Hs29-4T cells were cultured in Dulbecco's modified Eagle's medium
supplemented with 10% fetal calf serum, in a 10% CO2 humidified atmo-sphere. Experimentsunderhypoxic conditions (1%O2)wereperformed in
the hypoxic incubator. For transient transfections, Hs29-4T cells were
plated in 60-mm cell culture dishes and grown to 80% confluence. The
siRNA was diluted to a final concentration of 20 nM. Transfections were
performed using Lipofectamine (Invitrogen), following the manufac-
turer's recommendations, 48 h before treatment with the indicated
conditions. See Supplementary Fig. 1 for immunoblot analysis.
In vitro migration and invasiveness assays
Hs29-4T cell invasion was assayed with the Transwell system of
Costar, equipped with 8-μm pore-size polyvinylpyrrolidone-free
polycarbonate filters (diameter, 13 mm). Migration or invasiveness
assays are distinguished by the absence (migration assay) or the
presence (invasiveness assay) of a 3D barrier of Matrigel. Matrigel (BD
Biosciences) was diluted (30 μg in 100 μl of H2O), added to the top
chamber, allowed to solidify for 1 h at 37 °C, and air dried for 16 h. The
Matrigel barrier was reconstituted with 100 μl of Dulbecco's modified
Eagle's medium for 2 h at 37 °C before use. Cells were loaded into the
upper compartment (5×104 cells in 300 μl) in serum-deprived
growth medium. The Matrigel invasion chambers were placed into
six-well culture dishes containing 500 μl of Dulbecco's modified
Eagle's medium with 10% serum as a chemoattractant. After 24 h of
incubation at 37 °C under hypoxic and normoxic conditions, non-
invading cells and the Matrigel layer were mechanically removed
using cotton swabs, and the microporous membrane containing the
invaded cells was fixed in 96% methanol and stained with Diff-Quick
staining solutions. Chemotaxis was evaluated by counting the cells
that migrated to the lower surfaces of the polycarbonate filters. The
numbers of cells in six randomly chosen fields were determined for
each filter, and the counts were averaged (means±SD).
In vitro vasculogenic mimicry assay
The experiments were performed using growth factor-reduced
Matrigel at a concentration of 1 mg/ml. Sixty microliters of Matrigel
was added to each well of a 96-well plate, allowed to gel for 15 min at
room temperature, and then placed in a humidified atmosphere at
37 °C. Cells (2×104 cells per well) were added to the Matrigel-coated
plates in a final volume of 200 μl. The cells were then incubated under
hypoxic or normoxic conditions. Thirty-six hours later, images of each
well were taken using phase-contrast microscopy.
Assay of intracellular ROS
Intracellular production of H2O2 was assayed as previously
described [26]. Five minutes before the end of the incubation time,
the cells were treated with 5 μg/ml DCF-DA. After being washed with
PBS, the cells were lysed in 1 ml of RIPA buffer and analyzed
immediately by fluorimetric analysis at 510 nm. Data were normal-
ized to total protein content. Alternatively ROS were measured using
Amplex red (Invitrogen), according to the manufacturer's protocol.
Cells were lysed in 100 μM Amplex red reagent supplemented with
0.2 U/ml horseradish peroxidase and incubated in the dark for 30 min.
Fluorescence was measured in 96-well plates at 590 nm.
Western blot analysis
Hs29-4T (1×106) cells derived from our experimental conditions
were lysed for 20 min on ice in 500 μl of complete RIPA lysis buffer
(50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 2 mM EGTA,
1 mM sodium orthovanadate, 1 mM phenylmethanesulfonyl fluoride,
10 μg/ml aprotinin, 10 μg/ml leupeptin). Lysates were separated by SDS/
PAGEand transferredontonitrocellulose. Immunoblotswere incubated in
3% bovine serum albumin, 10 mM Tris–HCl (pH 7.5), 1 mM EDTA, and
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antibodies and then with secondary antibodies.
Cell adhesion and spreading
Cells (106) were serum starved for 24 h before being detached
with 0.25% trypsin for 1 min. Trypsin was blocked with 0.2 mg/ml
soybean trypsin inhibitor, and the cells were resuspended in 2 ml of
fresh medium per 10-cm dish, maintained in suspension for 30 min at
37 °C, and then directly seeded onto culture dishes for various times.
Images of each point were taken using phase-contrast microscopy.
Generation of TetO-shRNA inducible vector for Met silencing
By PCR technology we engineered the pSuper plasmid, substitut-
ing the last portion of the H1 promoter with the TetO sequence to
obtain the pSuper TetO vector [27].We then inserted into pSuper TetO
(BglII, HindIII) the already published MET (5′-GUCAUAGGAAGAGGG-
CAU-3′) and Control (5′-CUCAUAGGAAGACCCCAUU-3′) targeting
sequences [11] and the MET221 (5′-GTGCAGTATCCTCTGACAG-3′)
targeting sequence [28] to obtain the pSuper TetO-shRNA. We moved
(EcoRI, HindIII) the entire construct into the BbsI site of the lentiviral
vector pCCLsin.PPT.hPGK.GFP.Wpre [29]. For the TetR vector, the TetR
sequence was obtained from pCDNA6/TR and cloned (MscI, NheI) into
the lentiviral vector p156RRLsin.PPThCMV.MCS.pre under the control
of the cytomegalovirus promoter. See Supplementary Fig. 1 for immu-
noblot analysis.
Lung colonization assays
Experiments were conducted in accordance with national guide-
lines and were approved by the ethics committee of the Animal
Welfare Office of the ItalianWorkMinistry and conformed to the legal
mandates and Italian guidelines for the care and maintenance of
laboratory animals. Six- to eight-week-old female SCID-bg/bg mice
(Charles River Laboratories International,Wilmington, MA, USA)were
injected with Hs29-4T cells. Mice (five animals per group) were
injectedwith 2×106 Hs29-4T cells resuspended in 0.2 ml of PBS in the
lateral tail vein. The mice were monitored every 3 days and sacrificed
after 40 days. Lungs were inspected for metastatic nodules and also
weighed to evaluate the total mass of metastases. Organs were fixed
overnight at 4 °C in formalin (5% in PBS) for histological analyses.
Statistical analysis
Data are presented as means±SD from at least three independent
experiments. Statistical analysis of the data was performed using the
Student t test. P values of≤0.001were considered statistically significant.
Results
Hypoxia induces a more aggressive phenotype in Hs29-4T melanoma
cells
A preliminary screening of growth factor receptors (GF-Rs)
regulated by hypoxia on Hs29-4T melanoma cells, including HGF-R/
Met, VEGF-R1, VEGF-R2, EphA2, EphA3, EphB2, platelet derived growth
factor β receptor (PDGF-R), and fibroblast growth factor-2 receptor,
indicated that 1% O2 mainly leads to increased expression of Met,
showing only a marginal effect on VEGF-R2 and being ineffective at the
regulation of the other GF-Rs (Supplementary Fig. 1). Hs29-4T
melanoma cells were exposed for 24 h to 1% O2 hypoxia, leading to
the expression of HIF-1α, the known regulator of the transcriptional
hypoxic response, as well as increasing the expression of the proto-
oncogene Met. In addition, there was a strong increase in tyrosine
phosphorylationofMet due tohypoxia, probably allowing the activationof the kinase and of a scattering/motile behavior (Fig. 1A). Melanoma
cells exposed to hypoxia were then analyzed for their adhesion onto
fibronectin-coated surfaces. The results indicate that 1% O2 hypoxia
causes a severe increase in the rate of spreading of these cells (Fig. 1B).
Hypoxia is highly effective in increasing the ability of melanoma cells to
move in a 3D motility assay (Fig. 1C, left), thereby confirming a shift
toward a more motile phenotype. In addition to motility we analyzed
the effect of hypoxia on the cell ability to cross 3D barriers. The results
revealed that hypoxia elicits a proinvasive program in melanoma cells,
leading to increased invasiveness (Fig. 1C, right).
The ability tomimic the vasculature, originally observed inmelanoma
cells and now extended to other cancer models, has been described as a
key feature of melanoma malignancy [30,31]. Exposure to hypoxia was
able to strongly increase the vasculogenic mimicry of melanoma cells,
assayed as their ability to self-organize into vascular-like networks onto
Matrigel surfaces (Fig. 1D). Together, these data validate hypoxia as a
microenvironmental cue successful in eliciting a wide proinvasive and
pseudoangiogenic program in Hs29-4T melanoma cells.
Exposure of Hs29-4T melanoma cells to hypoxia leads to ROS generation
and HIF-1α stabilization
Mild hypoxic conditions (1–3% O2) have been correlated with
oxidative stress, mainly driven by a deregulated mitochondrial electron
transport chain [18]. Studies have shown that these mitochondrion-
derived ROS stabilize and activate HIF-1α, most probably viamodulation
of PHDactivity [18]. To evaluate ifHs29-4Tmelanomacells sensehypoxia
through a redox-basedmechanism,wefirst evaluated ROS levels in these
cells under normoxic and hypoxic conditions, using either DCF-DA or
Amplex red redox-sensitive probes. Figs. 2A and B reveal that culture of
cells for 24 h in the presence of 1% O2 causes a 10-fold increase in
intracellular ROS content. Exposure to 1%O2 is themost effective in terms
of ROS delivery (Supplementary Fig. 2). Treatment with selective
inhibitors of intracellular ROS sources indicates mitochondria as the
main origin, with a marginal contribution by NADPH oxidase. In keeping
with the literature [18], the silencing of the Rieske Fe–S protein is
dramatically efficient at eliminating mitochondrial ROS, thereby con-
firming the involvement of mitochondrial complex III in ROS generation
during hypoxia. To analyze the role of these ROS in the stabilization of
HIF-1α and in the activation of its target Met we eliminated total
mitochondrial ROS by silencing the Rieske Fe–S protein, a component of
the mitochondrial transport electron chain acknowledged to produce
ROS in response to hypoxia [18], or by treating cells with rotenone
(inhibitor of mitochondrial complex I) or with a general scavenger of
oxidants such as NAC. Figs. 2C and D indicate that Hs29-4T melanoma
cells respond to hypoxia with a redox-dependent HIF-1α stabilization
and increased Met expression, complex III-derived ROS being the main
effectors.
Finally we analyzed the role of hypoxia-driven ROS on the motility
response induced by 1% O2. Our data indicate that the increased
spreading onto the ECM surface induced by hypoxia is largely dependent
on mitochondrial ROS (Fig. 3A), as well as the 3D motility response
(Fig. 3B). In addition, the increased ability to cross the 3D Matrigel, an
index of the invasiveness of melanoma cells, is again dependent on
hypoxia-drivenROS (Fig. 3C), aswell as the skill tomimic the vasculature
by forming vascular-like networks onto Matrigel surfaces (Fig. 3D).
We can conclude that mitochondrial ROS are key modulators
of the hypoxic response, acting on HIF-1α stabilization and on
the proinvasive and vasculogenic mimicry programs initiated by a
hypoxic microenvironment.
The hypoxic response of Hs29-4T melanoma cells is mainly HIF-1α-
dependent
To confirm the involvement of HIF-1 as the major executor of the
hypoxic response in the Hs29-4Tmelanomamodel, we silenced HIF-1α
Fig. 1. Hypoxia induces several phenotypic effects in Hs29-4T melanoma cells. (A) Hs29-4T cells were serum starved for 24 h and then incubated under hypoxia for 24 h. The cells
were lysed and immunoblots for HIF-1α, Met, phosphotyrosine (P-Tyr), and actin were performed. (B) Spreading assay. 24 h after starvation, cells were detached and presuspended
for 20 min in serum-free medium. The cells were exposed to hypoxia and adhesion onto culture dishes was allowed for the indicated times. Spread cells were counted in 10
randomly chosen fields for each sample and the means and SD are shown in the graph. (C) Left: Boyden migration assay. Cells after 24 h of starvation were allowed to migrate for
24 h under hypoxia toward medium with 10% serum as chemoattractant. For each filter the number of cells in 10 randomly chosen fields was determined, and the averages±SD
were then calculated. *Pb0.001 versus normoxia. Right: invasiveness assay. Invasiveness was evaluated as for the migration assay (left) except that Matrigel was used to represent
3D ECM. *Pb0.001 versus normoxia. (D) Analysis of vascular mimicry. Melanoma cells were seeded on Matrigel-coated dishes in serum-free medium and incubated under hypoxia
for 36 h. Cord formation was examined with a phase-contrast microscope and the bar graph quantifies the total number of junctions. *Pb0.001 versus normoxia. All data are
representative of at least three independent experiments.
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spreading, 3D motility, and invasiveness, as well as vasculogenic
mimicry of hypoxic cells (Fig. 4). The forced down-regulation of the
HIF-1α protein completely abolished the adhesive, motile, and
proinvasive effect induced by hypoxia (Figs. 4A–C). In addition,inhibition of expression of HIF-1α was able to severely impair the
ability of melanoma cells to self-organize in vascular-like structures
onto Matrigel-coated dishes (Fig. 4D). On this basis, HIF-1 is probably
the critical modulator of the motility program of aggressive melanoma
in a hypoxic environment.
897G. Comito et al. / Free Radical Biology & Medicine 51 (2011) 893–904The motility program engaged by hypoxia in aggressive melanoma relies
on Met activation
The proto-oncogeneMet is acknowledged to promotemotility and
scattering of cancer cells from their primary site, thus playing an
important role in the early stages of metastasis [11,32]. In additiontumor-associated hypoxia enhances transcription of theMet gene and
amplifies the invasive response of tumor cells to the ligand hepatocyte
growth factor [11]. These preliminary observations have provided the
rationale for investigating the significance of hypoxia-induced Met
activation during exposure of Hs29-4T melanoma to 1% O2. We first
confirmed that in Hs29-4T the hypoxia-driven Met overexpression is
HIF-1α-dependent (Fig. 5A). We therefore silenced the Met proto-
oncogene in Hs29-4T cells using an inducible lentiviral delivery
system of RNA interference. This system has already been accredited
in tumor cells overexpressing Met, in which Met silencing impaired
tumor growth and metastasis formation and maintenance [33]. As a
second approach we used the Met-selective tyrosine kinase inhibitor
PHA-665752, acknowledged to reverse lung premalignancy induced
by mutant K-Ras and to inhibit in vivo Met-dependent tumorigenicity
in various murine tumor models [34]. We thus assayed under
normoxic and hypoxic conditions the spreading/motility response
(Figs. 5B and C), as well as melanoma plasticity in terms of its ability to
form vascular-like structures upon Met silencing or inhibition
(Fig. 5D). Our observations support the notion that the activation of
the motile and proinvasive program of aggressive melanoma cells
exposed to hypoxia is strictly dependent on overexpression and
activation of Met. Indeed, Met silencing led to a dramatic decrease in
migration and invasion induced by hypoxia, as well as in the
vasculogenic mimicry (Figs. 5C and D). The effect of Met silencing
was less pronounced for spreading onto fibronectin (Fig. 5B).
Furthermore, the ability of the tyrosine kinase inhibitor PHA to fully
mimic the effect of Met silencing is in keeping with the idea that
hypoxia-driven Met overexpression leads to its activation.Hypoxia drives dissemination of aggressive melanoma cells through a
redox-dependent pathway involving HIF-1α and Met
To investigate if the redox-dependent HIF-1α/Met synergy is
required for metastasis onset, we chose a lung colony formation assay
in SCIDmice. This assay assesses the ability of tumor cells to survive in
the bloodstream, to extravasate, and to reside in a new location,
originating metastatic tumors. The tail-injection experimental metas-
tasis assay does not fully recapitulate the naturally occurring
metastatic process from the beginning, but it is widely considered a
valuable experimental tool to assess the intermediate and terminal
phases of the metastatic program. Indeed, our experimental design is
based on in vitro mimicry of hypoxic/oxidative environmental
conditions and in vivo analysis of lung colonization of conditioned
melanoma cells. To analyze the roles of both ROS delivery and Met
expression in hypoxia we silenced the Rieske protein and Met kinase.
Maintenance of Rieske protein and Met silencing was checked in vitro
for up to 9 days, a realistic time to influence homing and survival of
melanoma cells in lung parenchyma (Supplementary Fig. 4). After
24 h of hypoxic preconditioning we injected 1×106 Hs29-4T cells
silenced for Rieske protein or Met kinase into mouse tail veins. After
4 weeks mice of each experimental group were sacrificed to evaluateFig. 2. Hypoxia leads to an increase in intracellular ROS. (A) Hs29-4T cells were serum
starved for 24 h and treated under hypoxia with specific inhibitors of the various ROS
sources (20 mM NAC, 5 μM NDGA, 10 μM DPI, 1 μM rotenone) or transfected with
siRNA for Rieske Fe–S protein. Hydrogen peroxide production was evaluated with DCF-
DA and normalized to total protein content. *Pb0.001 versus untreated under hypoxia.
(B) Cells were treated as in (A) and hydrogen peroxide production was evaluated with
Amplex red reagent. *Pb0.001 versus untreated under hypoxia. (C) Melanoma cells,
after 24 h of starvation, were incubated under hypoxia for 24 h in the presence of
20 mMNAC and 1 μM rotenone. Lysates were used forWestern blot analysis for HIF-1α
and actin for normalization. (D) Cells were previously transfected with siRNA targeting
the Rieske Fe–S protein and, after 24 h of serum starvation, were exposed to 24 h of
hypoxia. Lysates were used for Western blot analysis for HIF-1α and Met, as well for
actin for normalization. All the results are representative of four independent
experiments.
Fig. 3. ROS are essential mediators of the hypoxic response. (A) Cells were serum starved for 24 h, then treated under normoxia or hypoxia with 20 mM NAC and 1 μM rotenone for
24 h, and spreading assay was performed. Spread cells were counted in 10 randomly chosen fields for each sample and the means and SD are shown in the graph. (B) Left: cells were
treated as in (A) and allowed to migrate for 24 h toward medium with 10% serum as chemoattractant; averages±SD values are shown in the bar graph. #Pb0.001 versus untreated
under normoxia; *Pb0.001 versus untreated under hypoxia. Right: cells were previously transfected with siRNA for Rieske Fe–S protein and, after 24 h of serum starvation, migration
was evaluated as on the left. *Pb0.001 versus untreated under hypoxia. (C) Left: cells were treated as in (B) and invasiveness was determined using a Boyden chamberwithMatrigel.
#Pb0.001 versus untreated under normoxia; *Pb0.001 versus untreated under hypoxia. Right: cells were treated as in (B) and invasiveness was evaluated using a Boyden chamber
with Matrigel. *Pb0.001 versus untreated under hypoxia. (D) Analysis of vascular mimicry. Cells were treated as in (A) and maintained under hypoxia for 36 h and cord formation
was examined with a phase-contrast microscope. The bar graph quantifies the total number of junctions. #Pb0.001 versus untreated under normoxia; *Pb0.001 versus untreated
under hypoxia. All data are representative of at least three independent experiments.
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Fig. 4. The hypoxic response is HIF-1α-dependent. (A) Cells were transiently transfected with siRNA targeting HIF-1α for 48 h and serum deprived for 24 h and a spreading assay was
performed. Spread cells were counted in 10 randomly chosen fields for each sample and the means±SD are shown in the graph. (B) Cells were treated as in (A) and allowed to
migrate for 24 h toward medium with 10% serum as chemoattractant; the averages±SD are shown in the bar graph. *Pb0.001, siRNA HIF-1α under hypoxia versus untreated–
hypoxia. (C) Cells were treated as in (A), and invasiveness was determined using a Boyden chamber with Matrigel. *Pb0.001 treated under hypoxia versus untreated–hypoxia. (D)
Cells were treated as in (A) andmaintained under hypoxia for 36 h and vascular mimicry was examined with a phase-contrast microscope. The bar graph quantifies the total number
of junctions. *Pb0.001 versus untreated–hypoxia. All data are representative of at least three independent experiments.
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strong increase in the number of melanoma colonies, suggesting that
the hypoxic preconditioning of melanoma cells is sufficient to give
them a prometastatic spur (Fig. 6A). The number of lung colonies is
greatly decreased in cells with the Rieske protein or Met kinase
silenced, confirming the roles of both mitochondrial ROS generation
and Met expression in metastatic lung colonization of melanoma cells
(Fig. 6A). In a further experiment, the preconditioning of hypoxic
Hs29-4Tmelanoma cells with NAC to scavenge intracellular ROS, with
rotenone to eliminate mitochondrial ROS, or with PHA to inhibit Met
tyrosine kinase activity confirmed our observations on metastatic
growth (Fig. 6B). Indeed, after 24 h of hypoxic preconditioning (and
1 h pretreatment with NAC/rotenone/PHA) we injected 2×106 Hs29-
4T cells into tail veins, and 6 weeks later the animals were sacrificed
and lungs inspected. Because of the large and confluent superficiallung metastases, lungs were weighed and total tumor load is reported
in Fig. 6B. Lung slices were stained with hematoxylin and eosin (H&E)
(Fig. 6C) [31]. The specificity of the hypoxic response was confirmed
by the ability of HIF-1α siRNA to block the increase in lung
colonization. Upon Met inhibition, as well as ROS removal by NAC
or inhibition of mitochondrial release of ROS by rotenone, animals
showed a reduced total lung metastatic load (Figs. 6B and C).
In the last experiment we also examined the morphology of large
metastases to analyze melanoma vasculogenic mimicry, i.e., the unique
ability of aggressive melanoma cells to form tubular structures and
patterned networks in three-dimensional culture that mimic embryonic
vasculogenic structures [31]. Indeed, histological analysis ofmelanomaor
in vivo use of intravenous tracers has revealed the architecture of
aggressive melanoma to consist of nonvascular laminin-rich networks
surrounding tumor cells and containing red blood cells, possibly serving
Fig. 5. The hypoxic response is Met-dependent. (A) Cells were transfected with siRNA for HIF-1α, starved for 24 h, and then incubated under hypoxia for an additional 24 h. The cells
were then lysed and analyzed by anti-HIF-1α, anti-Met, and anti-actin immunoblots. In the bar graph we report the ratio between values obtained by densitometric analysis of the
anti-HIF-1α and anti-Met immunoblots normalized to those obtained for the actin immunoblot. (B) Cells were permanently transduced with TetR control or TetR Met shRNA. The
cells were treated with doxycycline (1 μg/μl for 48 h) or with 150 μM PHA, a selective inhibitor of Met kinase. The cells were serum starved for 24 h, and then spreading was
evaluated. The means±SD are shown in the graph. (C) Left: cells were treated as in (B) and allowed to migrate for 24 h toward medium with 10% serum as chemoattractant; the
averages±SD are shown in the bar graph. *Pb0.001, TetR shRNAMet versus TetR control under hypoxia; #Pb0.001, PHA versus untreated under hypoxia. Right: cells were treated as
in (B) and invasiveness was determined using a Boyden chamber with Matrigel. The averages±SD are shown in the bar graph. *Pb0.001, TetR shRNAMet versus TetR control under
hypoxia; #Pb0.001, PHA versus untreated under hypoxia. (D) Cells were treated as in (B) and incubated under hypoxia for 36 h and cord formation was examined with a phase-
contrast microscope. The bar graph quantifies the total number of junctions. *Pb0.001 versus untreated under hypoxia. All data are representative of at least three independent
experiments.
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note, tumors exhibiting vasculogenicmimicryhave apoorprognosis [36].
The analysis of laminin/H&E-stained lung metastases reveals thatactivation of the ROS/HIF-1/Met axis is mandatory for in vivo vasculo-
genic mimicry. Indeed, metastases obtained from hypoxic cells show a
high level of laminin staining, aswell as several non-endothelial cell-lined
901G. Comito et al. / Free Radical Biology & Medicine 51 (2011) 893–904channels filled with red blood cells (Fig. 6D). Both laminin staining and
formation of vascular-like channels are totally absent from tumors from
normoxic cells, or from hypoxic cells silenced for HIF-1α, or treated with
inhibitors of mitochondrial ROS delivery orMet kinase (Fig. 6D), thereby
confirming the biological significance of this molecular pathway for
vasculogenic mimicry of aggressive melanoma.
Taken together these data indicate that in Hs29-4T melanoma cells
oxidative stress after hypoxia leads to persistent expression of HIF-1α
and its target Met, a mandatory prerequisite sufficiently recapitulating
the early phases of cancer progression towardmetastatic colonization of
lungs.
Discussion
The results presented in this report lead to these major conclusions:
(1) in Hs29-4T human melanoma cells hypoxia leads to a redox-
dependent stabilization of HIF-1α, mainly mediated by mitochondrial
ROS, and (2) HIF-1α accumulation, in turn, leads to enhanced expression
and activation of the proto-oncogene Met and to activation of: (i) the
motogenic program, (ii) invasiveness and ability to disseminate
metastatic colonies of melanoma cells, and (iii) the skill to mimic the
vasculature, forming capillary-like structures and expressing a latent
“pseudoangiogenic” program. Hence, activation of Met-driven moto-
genic/invasive pathways by HIF, in which ROS are mandatory players,
may represent an escape, oxygen-seeking strategy to avoid the hypoxic
hostile environment.
Although the involvement of ROS as procarcinogenic agents has been
strongly supported by the past literature [37–39], their role in the
acquisition of an invasive and malignant phenotype is still not fully
understood. It is well established that NADPH oxidase is responsible for
the generation of intracellular ROS triggered by several growth factors
such as PDGF, HGF, insulin, and VEGF, as well as integrins, thereby
triggering many of the effects elicited by these factors, including cell
proliferation, migration, cytoskeletal remodeling, angiogenesis, and
regulation of genes associated with tumor metastasis [39,40]. Mild
hypoxia, ranging from 1 to 3%, has already been reported to generate a
state of oxidative stress. During hypoxia, ROS have been reported to be
mainly produced by deregulated mitochondria through complexes I, III,
and IV, although complex III is the only mitochondrial complex able to
release ROS on the cytoplasmic side of the membrane and to contribute
cytoplasmic oxidants [18,41]. In endothelial cells, NADPH oxidase has
been indicated as a source of ROS in hypoxia as well [40]. In keepingwith
these indications, in the Hs29-4T melanoma model, hypoxia-driven ROS
are mainly produced by the mitochondrial electron transfer chain, as
indicated by the ability of rotenone to counteract ROS generation;
complex III is likely to be the main source, as revealed by the effect of
silencing of Rieske Fe–S protein, a component of the complex III ubiquinol
Q cycle. Althoughwe cannot exclude a contribution of NADPH oxidase to
hypoxic oxidative stress, the ability of diphenylene iodonium (DPI), a
flavin-dependent oxidase inhibitor, to decrease ROS release during
hypoxia and to block HIF-1α accumulationmay be explained by its effect
on the flavoproteins of the mitochondrial electron transfer chain.
The state of the art strongly implicates ROS in the activation of the
epithelial–mesenchymal transition (EMT) in several cancer models,
including melanoma. Rac1b, a differentially spliced form of Rac1, has
been reported to generate carcinogenic ROS during metalloprotease-
induced EMT of mammary epithelial cells [42]. In keeping with this,
Rac1-mediated redox signaling has been reported as vital formelanoma
aggressiveness upon expression and activation of Met, a known
regulator of the EMT [32,43]. Hypoxia has already been correlated
with EMT and the consequent acquisition of a motile/invasive behavior
[44]. In several epithelial cancers, hypoxia-driven generation of ROS
revealed a redox regulation of early EMT-related events induced by
hypoxia such as activation of the Snail and Twist transcription factors,
which are probably engaged in the transcription of HIF-1α and VEGF
[44]. Our data confirm a key role for hypoxia-driven ROS in aggressivemelanoma, through HIF-1α accumulation andMet-induced expression,
leading to the achievement of a motile and invasive behavior. Indeed,
elimination of mitochondrial ROS release, counteracting HIF-1α
accumulation, and inhibition of Met activity or expression are all able
to strongly decrease the aggressiveness of Hs29-4T melanoma cells,
both in vitro and in vivo.
In the melanomamodel studied, hypoxia-driven ROS are absolutely
mandatory to allow accumulation of HIF-1α. Although the involvement
of EMT-related events is possible and could in principle lead to an
accumulation of HIF-1α through activation of the Twist transcription
factor [45], in hypoxic Hs29-4T cellswe did not detect the activation of a
clear EMT transcriptional program, as indicated by E-cadherin preser-
vation and the inability to express Twist or Snail transcription factors
(data not shown). Hence, we think that HIF-1α accumulation due to
hypoxic ROS may be explained through the redox-mediated inactiva-
tion of PHDs, in which ROS enzymatically inactivate PHDs through a
Fenton reaction with the catalytic Fe2+ [18,41,46]. In keeping with this
idea, in other cancer models mitochondrial DNA mutations associated
with increased generation of ROS promote normoxic accumulation of
the factor [47] and H-Ras stabilizes the hypoxic factor through the
generation of superoxide anion [48].
Hypoxia promotes tumor progression essentially by two mecha-
nisms. First, deep hypoxia, because of its toxicity to both normal and
tumor cells, selects for cells with mutations that allow survival under
these extreme conditions [49,50]. Second, hypoxia activates several
signaling pathways triggering de novo vascularization and facilitating
tumor cell invasion, migration, and adhesion, thereby contributing to
tumor malignancy. In addition to activation of proper neoangiogen-
esis, hypoxia has also been linkedwith the ability of melanoma cells to
organize into perfusable vascular-like networks, a process called
vasculogenic mimicry, serving for metastatic dissemination [25]. Our
data indicate that ROS, HIF-1α stabilization, and the consequent Met
overexpression and activation are strongly involved in hypoxia-
mediated vasculogenic mimicry. The effects of intratumoral hypoxia
in stimulating vasculogenic mimicry of melanoma may contribute a
possible explanation for the astonishing prometastatic effect of
angiogenesis inhibitors [5–7], totally inactive on nonendothelial de
novo vascularization. Indeed it is possible that cells exposed to
hypoxia after VEGF-targeted therapies exploit nonendothelial perfu-
sable networks to escape the primary tumor and disseminate
metastases. In this light, activation of the ROS/HIF/Met invasive
program by hypoxia leads to overcoming the need for the “angiogenic
shift” of tumors.
The Met proto-oncogene, encoding the tyrosine kinase receptor for
HGF, senses hostile environmental conditions and drives cell invasion
and metastasis, and its overexpression has been correlated with poor
prognosis of cancers [32,34]. Overexpression of the proto-oncogene Met
has already been reported to be induced by HIF-1, as well as leading to
constitutive activation of the receptor [11]. Notably, Met silencing in
already established metastases led to their almost complete regression,
indicating that persistent expression of Met is mandatory until the
advanced phases of cancer progression [33]. ROS have already been
involved as downstream effectors of the Met proto-oncogene. Indeed,
expression of Met has been correlated withmelanoma aggressiveness in
B16mouse cells, andRac1-mediated redox signalinghas been reported to
be vital for expression andactivation ofMet [12].Weherein report that in
Hs29-4T melanoma cells hypoxia-driven ROS behave as upstream
modulators of Met expression and consequently of the activation of its
invasive program.We indeed report thatMet expression is dependent on
hypoxia-driven ROS, but the analysis of a reciprocal relationship among
mitochondrial ROS, HIF-1α, and Met revealed a precise hierarchy:
hypoxia leads to mitochondria deregulation and ROS generation, which,
in turn, stabilizes the HIF-1α transcription factor, whose effector arm in
the activation of the metastatic program is the Met proto-oncogene. Of
note, we correlate for the first time Met expression with the ability of
melanoma cells to form vessel-like structures, generally recognized as a
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several tumor types and strongly associated with a poor prognosis.
Activation of HIF-1α is mandatory for several responses, which,
coordinately, instruct aggressive cancer cells to escape from adverse
conditions within the primary tumor [51]. First, HIF-1 activates the
survival pathway, acting on inhibition of proapoptotic routes such as
Bad and Bid and activation of secretion of prosurvival factors such as
VEGF, Bcl-2, and myeloid cell leukemia-1 [51,52]. In addition, in
hepatoma cells, mitochondrial ROS due to hypoxia lead to activation
of the prosurvival pathway driven by nuclear factor-κB, through
oxidation/activation of the kinase Src and phosphorylation of the p65
inhibitor of nuclear factor-κB [51,53]. This is a compulsory protection
system from an incremental danger, i.e., the decrease in O2. Second, HIF-
1α activates a metabolic shift toward a more reducing catabolism
involving glycolysis, producing NADPH through the pentose phosphate
pathway and excluding the strongly oxidizingmitochondria. Third, HIF-
1α elicits the metastatic escape program from the hostile hypoxic site.
Much evidence of the redox regulation of several key points of these
three programs is available in the literature and was recently reviewed
by Snyder and Chandel [41] and Pani et al. [51]. Here we propose that
hypoxia-driven ROS, through stabilization of the master regulator HIF-
1α and transcriptional regulation of Met, are central players in the
various strategies adopted by cancer cells to escape from unfavorable
sites and suggest that hypoxic conditions and ROS can hierarchically
cooperate in inducing metastasis outcomes.
The findings reported herein significantly contribute to our
understanding of the role of ROS in tumor progression, changing the
current perspective that oxidants mainly act by increasing oxidative
DNA damage and mutations. Recently, Gao et al. [20] analyzed three
different tumorigenic in vivo mouse models and elegantly showed
that antioxidants exert their antitumoral effect mainly acting on the
HIF-1α level. Our results extend the key role of HIF-1α redox
stabilization from carcinogenesis to metastatic dissemination of
aggressive tumors, suggesting antioxidant therapy as a promising
adjuvant treatment for malignant melanoma.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.freeradbiomed.2011.05.042.
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